Skip to content
lifestyle.latabloid.com/
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CRISPR Therapeutics AG
CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026
August 28, 2026
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results
August 3, 2026
CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference
May 21, 2026
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 21, 2026
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
April 7, 2026
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
March 11, 2026
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
March 10, 2026